– Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24...
Nonclinical findings provide evidence of the mechanism of action of nomlabofusp and support the potential use of skin FXN concentrations...
Biotech veteran will lead clinical development of Diagonal’s clustering antibody pipeline, including DIAG723 for hereditary hemorrhagic telangiectasia (HHT) and pulmonary...
Adagene to provide proprietary antibody to ConjugateBio for development as novel bispecific ADCs SAN DIEGO and SUZHOU, China and PRINCETON,...
CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate...
Full results from REGEN-007 are being held and will be submitted to the American Society of Nephrology 2025 Kidney Week...
Microbix to Develop New Products using NCIPD Organism CollectionMISSISSAUGA, Ontario and SOFIA, Bulgaria, July 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc....
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for...
- NDA assigned a Target Action Date of February 25, 2026 -- Product has patent protection through 2044 - DEER...
With renewed financial strength, WeightWatchers accelerates its transformation with the appointment of key executives including Dr. Kim Boyd as Chief...
- IDE approval obtained; U.S. pilot study clinical site launched at Johns Hopkins- Series B round in planning to support...
With a patent-pending formula and international expansion underway, BioAro positions itself as a front-runner in the multi-billion-dollar longevity and wellness...
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 1.925 MILLION PRIVATE PLACEMENT Paris, July 8, 2025, 8am...
Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries...
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a...
ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage...
The Company's aim is to seek FDA consent to fast track the Clinical Development Program to treat Basal Cell Carcinoma...
Global Biopharma Leader Streamlines Pharmacovigilance with 90% Data Accuracy and Enhanced Efficiency BOSTON, July 8, 2025 /PRNewswire/ -- ArisGlobal, an AI-first...
GLENBROOK, Nev., July 8, 2025 /PRNewswire/ -- Aphobic, the world's first AI-powered phobia relief app from Rockridge AI, Inc., launches...
SEOUL, South Korea, July 8, 2025 /PRNewswire/ -- AIRS Medical, a leader in AI solutions for diagnostic imaging, has received...